Clovis Oncology prices upsized $205M share offering

|About: Clovis Oncology (CLVS)|By:, SA News Editor

Clovis Oncology (CLVS -3.3%) has priced a now-upsized public offering of $205M in common stock.

The company planned a $175M offering, and has raised terms now to 5M shares at $41/share. Underwriters have a typical 30-day option to buy up to an additional 750,000 shares on the same terms.

The offering's expected to close Jan. 9. J.P. Morgan and BofA Merrill Lynch are joint book-runners, with Stifel and SunTrust Robinson Humphrey co-managers.

After hours, shares are down another 1.4% to $42.37.

Subscribe for full text news in your inbox